Jeff Berkowitz

Jeff Berkowitz has a diverse work experience. Jeff is currently the CEO of Real Endpoints since September 2018. Jeff also serves on the board of directors for Lundbeck since March 2018, Zealand Pharma A/S since April 2019, and Esperion Therapeutics, Inc. since December 2017. Furthermore, they have been a director at Uniphar Group since September 2020. Jeff previously held executive positions at UnitedHealth Group as Executive Vice President from December 2015 to June 2017, and at Walgreens Boots Alliance as Executive Vice President, Walgreens Boots Alliance & President, Global Pharma & Market Access from August 2010 to August 2015. Jeff Berkowitz also had a role as a member of the board of directors at Infinity Pharmaceuticals from March 2014 to June 2020, and at Physicians Interactive from 2010 to 2013. Prior to that, they had various senior leadership roles at Merck, including Senior Vice President, Global Market Access from November 2009 to October 2010, and Group Vice President, Diversified Products and Global Market Access from 1998 to November 2009.

Jeff Berkowitz has a B.A. in Political Science from Union College. Jeff also attended Brooklyn Law School to pursue a degree in Law, but specific information about their degree is not provided.